The Centers for Medicare and Medicaid Services has expanded the definition of medical staff to include advanced practice nurses, physician assistants and pharmacists. CMS said the goal is to allow hospitals to explore new approaches to care by increasing the types of practitioners granted hospital privileges.
Drugs for cancer (Genentech), kidney (Aveo), and thyroid cancer (Exelixis) are three of eight drugs to watch at the American Society of Clinical Oncology coming in in June. Luke Timmerman at Xconomy explains why you should be watching these drugs that are on the cusp of reaching the market, or just beginning to scratch the surface of their potential.
Gilead Sciences Inc. got good news about Truvada from the FDA last week as an FDA advisory committee voted 19-3 to approve the medication for men who have sex with men. Three-dozen public witnesses from HIV community testified against the drug, saying that it could discourage the use of condoms and encourage the healthy to treat it as “a party drug” for weekend use.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sergey Brin and Anne Wojcicki are continuing to support research into Parkinson’s disease and are seeing some progress. They have donated $124.9 million to the Michael J. Fox Foundation for Parkinson’s Research and the foundation in turn has helped 23andMe get patients for its database of genetic information.
